AU Stock MarketDetailed Quotes

Clinuvel Pharmaceuticals Ltd (CUV)

Watchlist
  • 9.170
  • +0.050+0.55%
20min DelayMarket Closed May 1 16:00 AET
462.42MMarket Cap12.77P/E (Static)

Clinuvel Pharmaceuticals Ltd (CUV) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
Total revenue
7.76%95.02M
12.59%88.18M
19.17%78.32M
36.99%65.72M
47.32%47.98M
4.89%32.57M
21.82%31.05M
52.42%25.49M
169.19%16.72M
113.33%6.21M
Operating revenue
7.76%95.02M
12.59%88.18M
19.17%78.32M
36.99%65.72M
47.32%47.98M
4.89%32.57M
21.82%31.05M
52.42%25.49M
169.19%16.72M
113.33%6.21M
Cost of revenue
57.52%15.88M
14.70%10.08M
-16.16%8.79M
122.10%10.48M
-50.98%4.72M
40.14%9.63M
14.80%6.87M
47.68%5.99M
8.52%4.05M
43.48%3.73M
Gross profit
1.33%79.14M
12.32%78.1M
25.88%69.53M
27.70%55.24M
88.59%43.26M
-5.13%22.94M
23.98%24.18M
53.94%19.5M
411.49%12.67M
702.49%2.48M
Operating expense
11.01%33.4M
18.33%30.09M
27.73%25.43M
32.45%19.91M
30.19%15.03M
49.94%11.55M
4.72%7.7M
23.23%7.35M
-10.42%5.97M
-42.42%6.66M
Selling and administrative expenses
7.31%26.85M
10.89%25.03M
27.41%22.57M
38.81%17.71M
575.61%12.76M
25.75%1.89M
42.89%1.5M
-81.54%1.05M
-10.60%5.69M
-43.68%6.37M
-Selling and marketing expense
----
----
----
----
----
25.75%1.89M
42.89%1.5M
29.54%1.05M
4.33%811.43K
-2.97%777.73K
-General and administrative expense
7.31%26.85M
10.89%25.03M
27.41%22.57M
38.81%17.71M
--12.76M
----
----
----
-12.68%4.88M
-46.79%5.59M
Depreciation amortization depletion
3.42%1.18M
44.71%1.14M
4.17%789.41K
-12.03%757.83K
101.44%861.43K
99.67%427.63K
380.80%214.16K
-16.17%44.54K
108.17%53.14K
-3.82%25.53K
-Depreciation and amortization
3.42%1.18M
44.71%1.14M
4.17%789.41K
-12.03%757.83K
101.44%861.43K
99.67%427.63K
380.80%214.16K
-16.17%44.54K
108.17%53.14K
-3.82%25.53K
Other operating expenses
36.83%5.37M
89.25%3.92M
44.07%2.07M
2.10%1.44M
-84.73%1.41M
54.23%9.23M
-4.37%5.98M
2,747.85%6.26M
-17.42%219.71K
14.61%266.07K
Operating profit
-4.73%45.73M
8.85%48.01M
24.83%44.1M
25.18%35.33M
147.79%28.22M
-30.87%11.39M
35.64%16.48M
81.29%12.15M
260.14%6.7M
62.84%-4.18M
Net non-operating interest income (expenses)
73.06%4.97M
302.53%2.87M
138.96%713.14K
-43.41%-1.83M
-337.64%-1.28M
-1.20%537.04K
105.54%543.54K
0.02%264.45K
26.89%264.39K
-40.19%208.37K
Non-operating interest income
28.75%9.43M
87.54%7.32M
779.56%3.91M
29.77%444.07K
-39.21%342.2K
-0.31%562.93K
113.52%564.66K
0.02%264.45K
26.89%264.39K
-40.19%208.37K
Non-operating interest expense
0.19%4.46M
39.51%4.45M
40.38%3.19M
40.53%2.27M
6,152.14%1.62M
22.60%25.89K
--21.11K
----
----
----
Other net income (expenses)
531.47%851.91K
-125.87%-197.44K
-7.07%763.08K
166.46%821.15K
-258.14%-1.24M
-11.26%781.32K
81.23%880.48K
405.48%485.84K
-87.93%96.11K
69.38%796.53K
Other non-operating income (expenses)
531.47%851.91K
-125.87%-197.44K
-7.07%763.08K
166.46%821.15K
-258.14%-1.24M
-11.26%781.32K
81.23%880.48K
405.48%485.84K
-87.93%96.11K
69.38%796.53K
Income before tax
1.72%51.55M
11.19%50.68M
32.80%45.58M
33.48%34.32M
95.73%25.71M
-27.48%13.14M
39.96%18.11M
81.92%12.94M
325.58%7.11M
69.72%-3.15M
Income tax
2.24%15.38M
0.46%15.04M
11.39%14.97M
1,265.55%13.44M
128.04%984.4K
-18,057.49%-3.51M
93.14%-19.33K
-281.78K
0
0
Earnings from equity interest net of tax
Net income
1.50%36.17M
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
85.88%13.22M
325.58%7.11M
69.72%-3.15M
Net income continuous operations
1.50%36.17M
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
85.88%13.22M
325.58%7.11M
69.72%-3.15M
Noncontrolling interests
-66.54K
Net income attributable to the company
1.50%36.17M
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
84.16%13.22M
327.69%7.18M
69.72%-3.15M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
1.50%36.17M
16.44%35.64M
46.58%30.6M
-15.57%20.88M
48.55%24.73M
-8.20%16.65M
37.13%18.13M
84.16%13.22M
327.69%7.18M
69.72%-3.15M
Diluted earnings per share
0.98%0.722
15.51%0.715
46.34%0.619
-15.40%0.423
47.93%0.5
-10.11%0.338
35.74%0.376
85.91%0.277
312.86%0.149
70.83%-0.07
Basic earnings per share
2.87%0.718
18.10%0.698
46.65%0.591
-16.74%0.403
46.67%0.484
-9.84%0.33
37.08%0.366
86.71%0.267
304.29%0.143
70.83%-0.07
Dividend per share
0.00%0.05
25.00%0.05
60.00%0.04
0.00%0.025
0.00%0.025
25.00%0.025
0.02
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016
Total revenue 7.76%95.02M12.59%88.18M19.17%78.32M36.99%65.72M47.32%47.98M4.89%32.57M21.82%31.05M52.42%25.49M169.19%16.72M113.33%6.21M
Operating revenue 7.76%95.02M12.59%88.18M19.17%78.32M36.99%65.72M47.32%47.98M4.89%32.57M21.82%31.05M52.42%25.49M169.19%16.72M113.33%6.21M
Cost of revenue 57.52%15.88M14.70%10.08M-16.16%8.79M122.10%10.48M-50.98%4.72M40.14%9.63M14.80%6.87M47.68%5.99M8.52%4.05M43.48%3.73M
Gross profit 1.33%79.14M12.32%78.1M25.88%69.53M27.70%55.24M88.59%43.26M-5.13%22.94M23.98%24.18M53.94%19.5M411.49%12.67M702.49%2.48M
Operating expense 11.01%33.4M18.33%30.09M27.73%25.43M32.45%19.91M30.19%15.03M49.94%11.55M4.72%7.7M23.23%7.35M-10.42%5.97M-42.42%6.66M
Selling and administrative expenses 7.31%26.85M10.89%25.03M27.41%22.57M38.81%17.71M575.61%12.76M25.75%1.89M42.89%1.5M-81.54%1.05M-10.60%5.69M-43.68%6.37M
-Selling and marketing expense --------------------25.75%1.89M42.89%1.5M29.54%1.05M4.33%811.43K-2.97%777.73K
-General and administrative expense 7.31%26.85M10.89%25.03M27.41%22.57M38.81%17.71M--12.76M-------------12.68%4.88M-46.79%5.59M
Depreciation amortization depletion 3.42%1.18M44.71%1.14M4.17%789.41K-12.03%757.83K101.44%861.43K99.67%427.63K380.80%214.16K-16.17%44.54K108.17%53.14K-3.82%25.53K
-Depreciation and amortization 3.42%1.18M44.71%1.14M4.17%789.41K-12.03%757.83K101.44%861.43K99.67%427.63K380.80%214.16K-16.17%44.54K108.17%53.14K-3.82%25.53K
Other operating expenses 36.83%5.37M89.25%3.92M44.07%2.07M2.10%1.44M-84.73%1.41M54.23%9.23M-4.37%5.98M2,747.85%6.26M-17.42%219.71K14.61%266.07K
Operating profit -4.73%45.73M8.85%48.01M24.83%44.1M25.18%35.33M147.79%28.22M-30.87%11.39M35.64%16.48M81.29%12.15M260.14%6.7M62.84%-4.18M
Net non-operating interest income (expenses) 73.06%4.97M302.53%2.87M138.96%713.14K-43.41%-1.83M-337.64%-1.28M-1.20%537.04K105.54%543.54K0.02%264.45K26.89%264.39K-40.19%208.37K
Non-operating interest income 28.75%9.43M87.54%7.32M779.56%3.91M29.77%444.07K-39.21%342.2K-0.31%562.93K113.52%564.66K0.02%264.45K26.89%264.39K-40.19%208.37K
Non-operating interest expense 0.19%4.46M39.51%4.45M40.38%3.19M40.53%2.27M6,152.14%1.62M22.60%25.89K--21.11K------------
Other net income (expenses) 531.47%851.91K-125.87%-197.44K-7.07%763.08K166.46%821.15K-258.14%-1.24M-11.26%781.32K81.23%880.48K405.48%485.84K-87.93%96.11K69.38%796.53K
Other non-operating income (expenses) 531.47%851.91K-125.87%-197.44K-7.07%763.08K166.46%821.15K-258.14%-1.24M-11.26%781.32K81.23%880.48K405.48%485.84K-87.93%96.11K69.38%796.53K
Income before tax 1.72%51.55M11.19%50.68M32.80%45.58M33.48%34.32M95.73%25.71M-27.48%13.14M39.96%18.11M81.92%12.94M325.58%7.11M69.72%-3.15M
Income tax 2.24%15.38M0.46%15.04M11.39%14.97M1,265.55%13.44M128.04%984.4K-18,057.49%-3.51M93.14%-19.33K-281.78K00
Earnings from equity interest net of tax
Net income 1.50%36.17M16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M85.88%13.22M325.58%7.11M69.72%-3.15M
Net income continuous operations 1.50%36.17M16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M85.88%13.22M325.58%7.11M69.72%-3.15M
Noncontrolling interests -66.54K
Net income attributable to the company 1.50%36.17M16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M84.16%13.22M327.69%7.18M69.72%-3.15M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 1.50%36.17M16.44%35.64M46.58%30.6M-15.57%20.88M48.55%24.73M-8.20%16.65M37.13%18.13M84.16%13.22M327.69%7.18M69.72%-3.15M
Diluted earnings per share 0.98%0.72215.51%0.71546.34%0.619-15.40%0.42347.93%0.5-10.11%0.33835.74%0.37685.91%0.277312.86%0.14970.83%-0.07
Basic earnings per share 2.87%0.71818.10%0.69846.65%0.591-16.74%0.40346.67%0.484-9.84%0.3337.08%0.36686.71%0.267304.29%0.14370.83%-0.07
Dividend per share 0.00%0.0525.00%0.0560.00%0.040.00%0.0250.00%0.02525.00%0.0250.02
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Iran has announced its latest negotiation proposal: all issues should be resolved within 30 days, with the focus placed on 'ending the war' Show More